tiprankstipranks
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
US Market

Bioxytran (BIXT) Stock Price & Analysis

14 Followers

BIXT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.07 - $0.35
Previous Close$0.09
Volume11.40K
Average Volume (3M)116.26K
Market Cap
$15.99M
Enterprise Value$17.88M
Total Cash (Recent Filing)$26.09K
Total Debt (Recent Filing)$1.90M
Price to Earnings (P/E)
Beta-0.97
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding174,962,481
10 Day Avg. Volume103,444
30 Day Avg. Volume116,256
Standard Deviation2.72
R-Squared0.00028
Alpha0.57
Financial Highlights & Ratios
Price to Book (P/B)-6.56
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-45.10
P/FCF Ratio14.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

34.66%0.00%0.00%65.34%
34.66% Insiders
0.00% Other Institutional Investors
65.34% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

BIXT FAQ

What was Bioxytran Inc’s price range in the past 12 months?
Bioxytran Inc lowest stock price was $0.07 and its highest was $0.35 in the past 12 months.
    What is Bioxytran Inc’s market cap?
    Currently, no data Available
    When is Bioxytran Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Bioxytran Inc’s earnings last quarter?
    Currently, no data Available
    Is Bioxytran Inc overvalued?
    According to Wall Street analysts Bioxytran Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Bioxytran Inc pay dividends?
      Bioxytran Inc does not currently pay dividends.
      What is Bioxytran Inc’s EPS estimate?
      Bioxytran Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Bioxytran Inc have?
      Bioxytran Inc has 174,962,480 shares outstanding.
        What happened to Bioxytran Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Bioxytran Inc?
        Currently, no hedge funds are holding shares in BIXT
        ---

        Bioxytran Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        -60.90%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        -46.24%
        Trailing 12-Months

        Company Description

        Bioxytran Inc

        BioXyTran, Inc. is a pharmaceutical company, which engages in the development, manufacturing and commercialization of first-in-class treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. Its products include BXT-25, an anti-necrosis drug that carries oxygen to tissues when the flow of blood is blocked. The company was founded on October 5, 2017 and is headquartered in Newton, MA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Bioxcel Therapeutics
        BioCryst
        Benitec Biopharma
        BioNTech SE
        Sangamo Biosciences
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis